Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01466049 · ClinicalTrials.gov registry record
New Biomarkers Evaluating Ovarian Cancer
A clinical trial, sponsored by Fujirebio Diagnostics.
- Completed
- Registry status
- 280
- Enrollment target
NCT01466049 is a clinical trial that has completed, run by Fujirebio Diagnostics. The registered enrollment target is 280 participants.
The verdict
NCT01466049 has completed, sponsored by Fujirebio Diagnostics.
- COMPLETED
- Registry status
- 280 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate new biomarkers for patients presenting to a physician for surgery to remove a mass in their pelvis and to continue to evaluate these types of patients using the ROMA algorithm for post-market benefits.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 280 participants |
| Start Date | 2011-12 |
| Est. Completion | 2014-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01466049
The ClinicalTrials.gov registry entry for NCT01466049 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 280 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fujirebio Diagnostics, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01466049 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01466049 about?
NCT01466049 is a clinical study titled "New Biomarkers Evaluating Ovarian Cancer". The purpose of this study is to evaluate new biomarkers for patients presenting to a physician for surgery to remove a mass in their pelvis and to continue to evaluate these types of patients using the ROMA algorithm for post-market benefits.
What is the current status of trial NCT01466049?
This trial is currently completed. The enrollment target is 280 participants. The study started on 2011-12. Estimated completion is 2014-03.
Who is sponsoring clinical trial NCT01466049?
This trial is sponsored by Fujirebio Diagnostics, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.